Ładuje się......
Drug reformulations and repositioning in pharmaceutical industry and its impact on market access: reassessment of nomenclature
BACKGROUND: Medicinal products that have been developed and approved for one disease may be the object of additional clinical development in other disease areas or of additional pharmaceutical development for new and different formulations. The newly developed products can be named as repositioned o...
Zapisane w:
| Wydane w: | J Mark Access Health Policy |
|---|---|
| Główni autorzy: | , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Co-Action Publishing
2013
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4865745/ https://ncbi.nlm.nih.gov/pubmed/27226826 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3402/jmahp.v1i0.21131 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|